tm logo
XENCOR
FORMALIZED

on 27 Dec 2023

Last Applicant/ Owned by

XENCOR INC.

465 North Halstead Street,Suite 200Pasadena CA 91107

US

Serial Number

2302156 filed on 03rd Nov 2023

Correspondent Address

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

XENCOR

Trademark usage description

biochemicals, namely, antibodies and fragments thereof for research and development; biochemicals for general manufacturing; biochemicals for use in t Read More

Classification Information


Class [001]
Biochemicals, namely, antibodies and fragments thereof for research and development; biochemicals for general manufacturing; biochemicals for use in the manufacture of pharmaceuticals for the treatment of oncological and autoimmune diseases and disorders.


Classification kind code

12

Class [005]
Pharmaceutical preparations, namely, antibodies and proteins for the treatment of oncological and autoimmune diseases and disorders.


Classification kind code

12

Class [042]
Product development consulting in the fields of biotechnology and pharmaceuticals; product development for others in the fields of biotechnology and pharmaceuticals.


Classification kind code

12

Mark Details


Serial Number

2302156

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 256
on 28th Oct 2024
Notification of Possible Opposition Sent
Submitted for opposition 67
on 27th Sep 2024
Agent Name Changed
Submitted for opposition 48
on 25th Apr 2024
Agent Changed
Submitted for opposition 48
on 30th Jan 2024
Agent Changed
Submitted for opposition 257
on 28th Dec 2023
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 27th Dec 2023
Formalized
Submitted for opposition 1
on 27th Dec 2023
Created
Submitted for opposition 228
on 03rd Nov 2023
International Registration
Submitted for opposition 30
on 03rd Nov 2023
Filed